Amman-listed Philadelphia Pharmaceutical – Jordan announced its
financial statements for the fiscal year ending December 31, 2014,
reporting a profit surge by 364.5% to JOD 3.025 million ($4.25
million) compared to JOD 651.2 THD ($914.7 THD) during the same period
of 2013.
Moreover, operational revenues also soared by
132.03% to JOD 10.4 million during the period, compared to JOD 4.49
million.
The Company’s profit jumped 461.5% to JOD 2.529
million during the nine-month period ending September 30, 2014,
compared to JOD 450.4 THD during the corresponding period of 2013.
Philadelphia
Pharmaceutical’s capital amounts to JOD 3 million, distributed on 3
million shares at JOD 1 par value.
